CardioBrief: Impella No Better Than IABP in Cardiogenic Shock

(MedPage Today) — Underpowered IMPRESS trial shows no mortality benefit
via CardioBrief: Impella No Better Than IABP in Cardiogenic Shock
by

from Blogger http://ift.tt/2f6uQCY

via https://www.youtube.com/channel/UC6RqJb8h-y4xS4g-vzofotQ/videos

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s